<DOC>
	<DOC>NCT00683176</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of choline fenofibrate on the regression of macular edema in eyes of subjects with type 2 diabetes mellitus (T2DM) presenting with diabetic macular edema (DME)</brief_summary>
	<brief_title>Effect of Choline Fenofibrate (SLV348) on Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Inclusion Criteria With DME in at least one eye of the subject and this eye presenting with macula thickness ≥ 300 µm on OCT examination at baseline in at least one of the 5 following zones: center zone, or superior inner zone, or nasal inner zone, or inferior inner zone, or temporal inner zone, confirmed after central reading of the OCT; When laser treatment can be safely postponed by up to at least 3 months; With established T2DM and HbA1c &lt; 10%; With systolic blood pressure (SBP) or diastolic blood pressure (DBP) &lt; 160/90 mmHg; With documented elevated triglyceride levels (TG &gt;=150 mg/dL [1.70 mmol/L]) at the screening visit or in the previous 3 months. Exclusion Criteria Previous laser photocoagulation; Eye retinal thickening results from epiretinal membranes or vitreomacular traction; glaucoma; Poor visual acuity: visual acuity of 20/800</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>OCT</keyword>
</DOC>